Biotech · Private company · New York, NY, US
Adiutrix Therapeutics
Track this companyFree. Adds Adiutrix Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4HFiscal year 2026 · $1.1MNIH RePORTER 5R42HL176297-03 · fetched Nov 12, 2026
- Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4HFiscal year 2025 · $1MNIH RePORTER 4R42HL176297-02 · fetched Nov 12, 2026
- Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4HFiscal year 2024 · $350KNIH RePORTER 1R42HL176297-01 · fetched Nov 12, 2026